Catalyst Wire Dossier Catalyst Wire Dossier

INTERCEPT Blood System for Red Blood Cells

· Cerus Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INTERCEPT Blood System for Red Blood Cells, covering 2025-09-10 to 2025-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients [Phase 3]

See pricing